Business ExpansionAnnouncement of a significant business win in the Plasma segment with the award of 132 established plasma donation centers will increase the company's market share to approximately 50%.
Financial PerformancePaysign reported financial results with a revenue increase of 41% to $18.6 million and a 193.3% increase in adjusted EBITDA to $4.96 million, exceeding consensus expectations.
Strategic AcquisitionThe acquisition of Gamma Innovation expands Paysign's technology-driven solutions in the plasma donation industry and is expected to generate additional revenue.